in-hospital hyperglycemia
Conditions
Interventions
Test group A:Fully closed-loop automated insulin delivery technology
Test group B:Conventional subcutaneous insulin therapy
Sponsors
First People's Hospital of Yunnan Province
Eligibility
Sex/Gender
All
Age
18 Years to 55 Years
Inclusion criteria
Inclusion criteria: 1) agree to participate in the trial and sign the informed consent; 2) hospitalized patients with non-severe hyperglycemia receiving enteral/parenteral nutrition; 3) aged 18-55 years old; 4) need to receive subcutaneous insulin therapy; 5) glycosylated hemoglobin (HbA 1c) =12%; 6) Women of childbearing age must have a pregnancy test (ß-HCG) with a negative result before starting treatment, and both women of childbearing age and men (who have sex with women of childbearing age) must consent to the use of effective contraception.
Exclusion criteria
Exclusion criteria: Compliance with any one of the rules is excluded: 1) patients with gastroparesis, significant diabetic complications, recent acute macrovascular events, recent severe diabetic ketoacidosis or hypoglycemia, or receiving non-insulin antihyperglycemic drugs; 2) type 1 diabetes mellitus; 3) pregnancy and lactation; 4) current use of glucocorticoids or other drugs that may affect blood glucose; 5) participating in other clinical studies; 6) The investigator considered other conditions to be inappropriate for participation in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| time in range; | — |
Secondary
| Measure | Time frame |
|---|---|
| time above range, TAR;time beyond range;mean amplitude of glycemic excursions; | — |
Countries
China
Contacts
Public ContactCai Yunying
First People's Hospital of Yunnan Province
Outcome results
None listed